{"id":1243,"date":"2025-03-24T10:28:18","date_gmt":"2025-03-24T10:28:18","guid":{"rendered":"https:\/\/sites.abo.fi\/madness\/?post_type=events&p=1243"},"modified":"2025-03-24T10:28:20","modified_gmt":"2025-03-24T10:28:20","slug":"34th-biocity-symposium-transforming-drug-development-for-tomorrow","status":"publish","type":"events","link":"https:\/\/sites.abo.fi\/madness\/events\/34th-biocity-symposium-transforming-drug-development-for-tomorrow\/","title":{"rendered":"34th BioCity Symposium: Transforming Drug Development for Tomorrow"},"content":{"rendered":"\n

34th<\/sup> BioCity Symposium: Transforming Drug Development for Tomorrow<\/strong><\/p>\n\n\n\n

28th<\/sup>-29th<\/sup> August
On-site event
in Mauno Koivisto Centre, BioCity, Turku, Finland<\/p>\n\n\n\n

The 34th<\/sup> BioCity Symposium focuses on drug development across a range of disease groups and on various drug modalities. Despite of significant breakthroughs in medicine, there are still numerous conditions for which there are no curative treatments, or even therapies that would effectively slow down the disease progression. Therefore, novel drug targets need to be identified and new drugs need to be discovered to target the disease-driving mechanisms. In this symposium, we will focus on academic drug discovery and on mechanisms how the promising new compounds identified in academic setting can be converted to commercially viable industrial drug development programs. The symposium will also cover exciting new approaches to select the most suitable patient populations for the emerging therapies.<\/p>\n\n\n\n

Registration is now open!
<\/strong>Registration to the BioCity Symposium is open until Friday 15 August 2025<\/strong>, 23:59 (CET+1)Abstract submission is open until Friday 6 June 2025<\/strong>, 23:59 (CET+1).Please take a look at the registration details: https:\/\/biocityturku.fi\/biocity-symposium\/registration\/<\/a><\/p>\n\n\n\n

Speakers
Anniina F\u00e4rkkil\u00e4<\/strong>, University of Helsinki, Finland
Carmen Galan<\/strong>, University of Bristol, UK
Nathanael S. Gray<\/strong>, Stanford University, USA
Christian Heinis<\/strong>, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Switzerland
David Leppert<\/strong>, GeNeuro SA; University Hospital Basel, Switzerland
Richard Marais<\/strong>, Oncodrug Ltd, UK
Silvia Marsoni<\/strong>, IFOM, Italy
Maarit Merla<\/strong>, Finnish Drug Discovery Center Ltd, Finland
Francesca E. Morreale<\/strong>, The Francis Crick Institute, UK
H\u00e9lder A. Santos<\/strong>, University of Groningen, The Netherlands
Eric Vivier<\/strong>, Innate Pharma; Aix-Marseille University, France<\/p>\n\n\n\n

Organizing Committee
<\/strong>Laura Airas
Maija Hollm\u00e9n
Reko Leino
Olli Pentik\u00e4inen
Jessica Rosenholm
Jukka Westermarck (chair)<\/p>\n\n\n\n

More information about the event from https:\/\/biocityturku.fi\/biocity-symposium\/ <\/a>
If you have any questions regarding the event, please contact biocityturku@bioscience.fi  <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

34th BioCity Symposium: Transforming Drug Development for Tomorrow 28th-29th AugustOn-site eventin Mauno Koivisto Centre, BioCity, Turku, Finland The 34th BioCity Symposium focuses on drug development across a range of disease groups and on various drug modalities. Despite of significant breakthroughs in medicine, there are still numerous conditions for which there are no curative treatments, or even therapies…<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true,"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":""},"categories":[],"tags":[],"class_list":["post-1243","events","type-events","status-publish","hentry"],"acf":[],"lang":"en","translations":{"en":1243},"taxonomy_info":[],"featured_image_src_large":false,"author_info":[],"comment_info":"","pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events\/1243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/types\/events"}],"wp:attachment":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/media?parent=1243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/categories?post=1243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/tags?post=1243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}